Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc.

3.05
EUR
-0.21
(-6.43%)
-0.52EPS
703.45MMarket Cap
Feb 25Next Earn

Aclaris Therapeutics, Inc. Documents

Q2 FY2025 · Presentation

ACRS - Corporate Overview Presentation June 30 [Final] · 31 pages

Read Aclaris Therapeutics, Inc.'s results firsthand

Preview the first 2 pages of this presentation
Create a free account to start reading

Full documents are included with Professional

Q2 FY2025 documents